Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000671626 | SCV000796616 | uncertain significance | Fanconi anemia complementation group A | 2017-12-20 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001854625 | SCV002273272 | uncertain significance | Fanconi anemia | 2022-08-20 | criteria provided, single submitter | clinical testing | This sequence change replaces alanine, which is neutral and non-polar, with glycine, which is neutral and non-polar, at codon 840 of the FANCA protein (p.Ala840Gly). This variant is present in population databases (rs587778313, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with FANCA-related conditions. ClinVar contains an entry for this variant (Variation ID: 134255). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV000671626 | SCV002816290 | uncertain significance | Fanconi anemia complementation group A | 2021-09-08 | criteria provided, single submitter | clinical testing | |
ITMI | RCV000120928 | SCV000085096 | not provided | not specified | 2013-09-19 | no assertion provided | reference population |